Evaluation and management of hemorrhage during TURP
Evaluation and management of haemorrhage during TURP.... source your answer only from pubmed research articles and article reviewof literature
Summary
Haemorrhage during Transurethral Resection of the Prostate (TURP) is a significant concern due to its potential for morbidity and mortality. Management strategies include preoperative cessation of anticoagulant and antiplatelet medications, the use of pharmacologic agents like 5α-reductase inhibitors and tranexamic acid, and technical considerations such as bipolar and laser technologies to reduce bleeding risks[1][2][3]. Effective management requires a comprehensive approach to prevent and treat hemorrhage, considering both the surgical technique and pharmacological interventions.
Prevention Strategies
Preventing hemorrhage during TURP involves several key strategies:
- Preoperative Medication Management: Stopping anticoagulant and antiplatelet medications before surgery is crucial, although this requires careful assessment of thrombotic risks[1].
- Pharmacologic Interventions:
- 5α-reductase Inhibitors: Finasteride and dutasteride have been shown to reduce perioperative bleeding by decreasing microvessel density in the prostate[3].
- Tranexamic Acid: This antifibrinolytic agent has demonstrated efficacy in reducing blood loss during bipolar TURP, though more studies are needed to confirm its benefits across different surgical techniques[2].
- Surgical Techniques:
Management of Haemorrhage
In cases where hemorrhage occurs, management involves both immediate intervention and potential further procedures:
- Immediate Hemostasis: Endoscopic fulguration is often used initially to control bleeding[5].
- Advanced Interventions: In severe cases refractory to conventional methods, selective arterial embolization may be necessary to control hemorrhage[5].
- Monitoring and Supportive Care: Close monitoring of vital signs and fluid management is essential to prevent complications such as TUR syndrome[4].
Clinical Decision-Making
When deciding on the best approach for managing hemorrhage during TURP, clinicians must consider the patient's overall health status, the presence of comorbidities, and the specific surgical technique being used. This includes weighing the benefits of pharmacologic interventions against potential risks and ensuring that appropriate surgical equipment is available.
Patient Safety and Risks
Patient safety is paramount, with considerations including:
Sources
- https://pubmed.ncbi.nlm.nih.gov/21844906/
- https://www.scielo.br/j/eins/a/kkLGrpkcjRTk4tyQWpPNDnp/
- https://pubmed.ncbi.nlm.nih.gov/28650680/
- https://www.ncbi.nlm.nih.gov/books/NBK560884/
- https://pubmed.ncbi.nlm.nih.gov/19956198/
AI-generated answer based on the cited sources. Check the sources before applying it.